EUCTR2006-001097-24-DE进行中（未招募）不适用
Phase I/II study of continous infusion with 5-FU and weekly Oxaliplatin / Cetuximab combined with concurrent radiation as neoadjuvant treatment in locally advanced oesophageal squamous cell carcinoma. - OE-7
Technische Universitaet Muenchen, Medizinische Fakultaet0 个研究点开始时间: 2006年5月22日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Histologically confirmed oesophageal squamos cell carcinoma
- •- Potentially resectable locally advanced oesophageal carcinoma
- •- Locally advanced stage (>uT3 category / >uT2 in cervical cancer) according to endoscopic ultrasound and computed tomography
- •- Medically operable patient: risk-score <22 (Bartels)
- •- Age 18 to 70 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •- Distant metastases
- •- Tumour infiltration into the tracheo-bronchial system
- •- Previous chemotherapy or radiation in the area ot the chest
- •- Uncontrolled infectious disease
- •- Manifest cardiac insufficiency
- •- Histologically assured cirrhosis of the liver
研究者
相似试验
已完成
1 期
Phase I/II study of arterial infusion of 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancernresectable pancreatic cancerJPRN-UMIN000000573ara Medical University24
已完成
不适用
Pharmacokinetic study of continuous-infusional 5-FU for esophageal carcinomaEsophageal carcinomaJPRN-UMIN000036566Keio University, School of Medicine50
已完成
不适用
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origiCarcinoma of unknown primary originMalignant neoplasm without specification of siteCancerISRCTN63374575The Royal Marsden NHS Foundation Trust (UK)88
已完成
不适用
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without mitomycin-C in patients with neuroendocrine tumourseuroendocrine tumoursMalignant neoplasm of other endocrine glands and related structuresCancerISRCTN53478221The Royal Marsden NHS Foundation Trust (UK)
已完成
不适用
A Randomised Study of continuous infusion 5-Fluorouracil (5FU) with or without bolus Mitomycin-C in Patients with Advanced Pancreatic CancerPancreatic cancerMalignant neoplasm of pancreasCancerISRCTN61961630The Royal Marsden NHS Foundation Trust (UK)208